ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

Merck on path to bring COVID treatment pill to Japan

Japanese pharma sector works on own coronavirus drug candidates

Merck and startup partner Ridgeback Biotherapeutics have applied to the U.S. Food and Drug Administration for emergency use authorization for molnupiravir.   © Reuters

TOKYO -- The COVID-19 pill developed by Merck raises hope for a first at-home coronavirus treatment that can ease caseloads of overstretched health care systems, and its unit in Japan is already working to gain approval for the drug as early as this year.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more